BVHG Series 3 meeting

Friday, December 14, 2012

The Wellcome Collection Centre, Euston, London.

'Viral Hepatitis: Research sessions on participation in commercial trials'

 

PROGRAMME:

 

09:30 – 10:00 Arrivals and registration

MORNING SESSIONS: CLINICAL TRIALS IN VIRAL HEPATITIS

 

 10:00 – 10:30 ‘How to establish clinical research trials in your hospital – the

clinicians perspective’

Dr Daniel Forton - St George's Healthcare NHS Trust

 

10:30 – 10:50 ‘Navigating the regulatory process in clinical trials’

Christy Reeve - Imperial College Healthcare NHS Trust

 

10:50 – 11:10 ‘The role of the CRA’

Claire Anthony - Bristol-Myers Squibb

 

11:10 – 11:30 Tea and coffee break

 

11:30 - 11:50 ‘The role of the research network’

Dr Stephen Ryder - Nottingham University Hospitals NHS Trust

 

11:50 – 12:10 ‘How industry and the NHS can work together in clinical

research’

Dr Dimitar Tonev - Bristol-Myers Squibb

 

12:10 – 12:30 Round table Q&A session

 

12:30 – 13:30 Lunch

 

 

AFTERNOON PROGRAMME: COMMISSIONING HEPATITIS SEVICES

 

13:30 – 13:45 National HBV Audit

Dr Eleni Nastouli - University College London

 

13:45 – 14:15 Establishing standards for viral hepatitis services

Professor Graham Foster - Queen Mary University of London

 

14:15 – 14:45 Current state of commissioning for Hepatology services

                      Steve Callaghan - EQE Health Ltd

 

14:45 – 15:15 Debate – “This house believes that the treatment of complex

Hepatitis C should be focussed in regional centres”

 

                        For the motion: TBC

            Against the motion: Dr Aftab Ala

 

15:30 – 15:45 Conclusions and depatures

 

 

To register please email: events@basl.org.uk

< back